Roivant Sciences Ltd.

8 filings 2 distinct issuers Active 2018-01-16 → 2025-02-25

Track Record

Total filings

3 SCHEDULE · 5 SC

Distinct issuers

25% issuer diversity

Median stake

32.63%

58,118,422 avg shares

AI briefs cached

0/8

intent-classified filings

Backtested Performance · post-filing returns (split + dividend adjusted)

Median 30d

-1.2%

across 2 filings · win rate 0%

Median 60d

-5.6%

across 2 filings · win rate 0%

Median 90d

-6.3%

across 2 filings · win rate 0%

Median 1y

+25.6%

across 2 filings · win rate 100%

Anchor: closest trading day on/after filing's date_of_event. Source: Yahoo Finance daily adj_close. Past performance is not indicative of future results.

Filings · 8 total

Filed	Form	Issuer	Stake	Shares
2025-02-25	SCHEDULE	Arbutus Biopharma CorpABUS	20.50%	38,847,462	view →
2025-02-18	SCHEDULE	Arbutus Biopharma CorpABUS	20.50%	38,847,462	view →
2025-01-15	SCHEDULE	Immunovant, Inc.IMVT	56.90%	96,660,341	view →
2018-04-23	SC	Arbutus Biopharma CorpABUS	—	—	view →
2018-04-12	SC	Arbutus Biopharma CorpABUS	—	—	view →
2018-03-16	SC	Arbutus Biopharma CorpABUS	—	—	view →
2018-02-14	SC	Arbutus Biopharma CorpABUS	—	—	view →
2018-01-16	SC	Arbutus Biopharma CorpABUS	—	—	view →

Alert me when Roivant Sciences Ltd. files anything

Free. We email you when criteria match. One-click unsubscribe in every email.

Track this filer's every move in real time.

Custom alerts on filer activity · full feed access · daily intelligence · API. $1,500/mo. Pilots welcome.

Request a pilot →